PREDICT overview

The chancellor is set to present her spending review to parliament on 11 June, setting the budget for every government ......

Latest news bulletin | May 2nd – Midday Catch up with the most important stories from around Europe and beyond - latest news, ......

Respondr(R) TNF Indicates Likelihood of Patient Response to Costly IBD Treatment Before Initiation of Therapy SAN DIEGO, CA / ACCESS Newswire / April 29, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision-guided medicine, announces the novel Responder TNF blood test is now commercially available. Respondr TNF is the first test to predict an inflammatory bowel disease (IBD) patient's likelihood to respond to infliximab, adalimumab and their biosimilars prior to therapy...

UPPSALA, SE / ACCESS Newswire / March 26, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, a leader in blood-based biomarker assays in oncology, today announces that an abstract with DiviTum TKa in a biomarker algorithm will be presented by Karolinska Institutet (KI) at the annual AACR meeting in Chicago on April 25-30, 2025, providing the first evidence that DiviTum TKa in combination with inflammation protein biomarkers significantly improves the ability to stratify...

The 2023-2024 Georgia Milestones data reveals that third-grade literacy plays a pivotal role in students' long-term success. CHAPEL HILL, NORTH CAROLINA / ACCESS Newswire / March 13, 2025 / Third grade can be the make-or-break moment in a student's academic journey, and this year's 2023-2024 Georgia Milestones Assessment data underscores just how critical early literacy is. The results reveal a striking trend: districts that performed well in third grade saw continued success across all future...

NBC News' Christine Romans details the estimated economic costs caused by the devastation of the California wildfires and ......

Fox News' Chad Pergram provides details on congressional Republicans' first action cracking down on border security and illegal ......

Multiple studies show Nu.Q® NETs test could predict sepsis patients at risk of deteriorating PR Newswire HENDERSON, Nev., Oct. 31, 2024 HENDERSON, Nev. , Oct. 31, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has published a report , from its 'NETs in sepsis management' symposium at ESICM Lives 2024 last month, which concluded that Nu.Q ® NETs could be used to predict patients at greater risk of deteriorating from sepsis. The...